Pemazyre

(pemigatinib)
NO BOXED WARNING

Dosage & Administration

Cholangiocarcinoma:

Myeloid/lymphoid neoplasms with FGFR1 rearrangement:


All patients treated with PEMAZYRE:


Get Your Patient on Pemazyre

See your patient's specific prior authorization requirements including coverage restrictions and step therapies
Or select your Insurance from the list below:

Pemazyre Prescribing Information

Pemazyre Prior Authorization Resources

Most recent state uniform prior authorization forms

Pemazyre PubMed™ News